All News

Helmholtz Biomedical Engineering Initiative

AI, Transfer, Bioengineering, IBMI, Pioneer Campus,

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

Intricate network of red capillaries, a detailed view of microscopic blood vessels conveying vitality

New Research Findings, Bioengineering, IBMI,

New Imaging Technology Detects Early Signs of Heart Disease Through the Skin

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for…

A dynamic web of entities and people working together to foster and advance new ideas, technologies, and solutions.

Transfer, Bioengineering, IBMI, Pioneer Campus,

From Lab Bench to Startup: New Doctorate Program Offers Scientists a Venture-Building Path

Helmholtz Munich is partnering with Deep Science Ventures (DSV) and SPRIND, Germany’s Federal Agency for Disruptive Innovation, to support the Venture Science Doctorate (VSD) – a novel doctoral program designed to train scientists to build…

Esophageal Cancer

New Research Findings, Bioengineering, IBMI,

New Endoscopy Technology Enables Early Detection of Esophageal Cancer

Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called "O2E" that allows clinics to detect cancerous lesions in the esophagus with…

A vibrant abstract composition shows interconnected blue dots and lines in a dark environment

Awards & Grants, Computational Health, ICB, Bioengineering, IBMI, Molecular Targets and Therapeutics, MCD,

Three ERC Proof of Concept Grants for Helmholtz Munich

Researchers at Helmholtz Munich have secured three prestigious Proof of Concept Grants from the European Research Council (ERC). This funding will enable them to advance innovative projects across diverse areas of biomedical research. With a total of…

Multiple Myeloma

New Research Findings, Bioengineering, IBMI,

New Label-Free Imaging Tracks Cancer Treatment in Single Cells

Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells – without the need for dyes or labels. Their mid-infrared optoacoustic microscopy (MiROM)…